ABRILADA
ABRILADA
Approved
DIN Number
02511061
Drug Class
Human
Market Date
Mar 13, 2023
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02511061
AIG Number0150364003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AB04 ADALIMUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
ADALIMUMABActive
Strength: 20 MG / 0.4 ML
Monograph: ADALIMUMAB